Bangma CH - Search Results

1

Compliance with biopsy recommendations of a prostate cancer risk calculator.

van Vugt HA, Roobol MJ, Busstra M, Kil P, Oomens EH, de Jong IJ, Bangma CH, Steyerberg EW, Korfage I. van Vugt HA, et al. Among authors: bangma ch. BJU Int. 2012 May;109(10):1480-8. doi: 10.1111/j.1464-410X.2011.10611.x. Epub 2011 Sep 20. BJU Int. 2012. PMID: 21933335 Clinical Trial.

2

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Urology. 1995 Dec;46(6):773-8. doi: 10.1016/S0090-4295(99)80342-2. Urology. 1995. PMID: 7502414

3

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Urology. 1995 Dec;46(6):779-84. doi: 10.1016/S0090-4295(99)80343-4. Urology. 1995. PMID: 7502415

4

Prostate-specific antigen: its clinical use and application in screening for prostate cancer.

Bangma CH, Blijenberg BG, Schröder FH. Bangma CH, et al. Scand J Clin Lab Invest Suppl. 1995;221:35-44. doi: 10.3109/00365519509090562. Scand J Clin Lab Invest Suppl. 1995. PMID: 7544483 Review.

5

Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.

Blijenberg BG, Bangma CH, Kranse R, Eman I, Schröder FH. Blijenberg BG, et al. Among authors: bangma ch. Eur J Clin Chem Clin Biochem. 1997 Feb;35(2):111-4. Eur J Clin Chem Clin Biochem. 1997. PMID: 9056753 Clinical Trial.

6

Prostate-specific antigen as a screening test. The Netherlands experience.

Bangma CH, Rietbergen JB, Schröder FH. Bangma CH, et al. Urol Clin North Am. 1997 May;24(2):307-14. doi: 10.1016/s0094-0143(05)70377-3. Urol Clin North Am. 1997. PMID: 9126228 Clinical Trial.

7

The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.

Bangma CH, Rietbergen JB, Kranse R, Blijenberg BG, Petterson K, Schröder FH. Bangma CH, et al. J Urol. 1997 Jun;157(6):2191-6. J Urol. 1997. PMID: 9146612 Clinical Trial.

8

Free and total prostate-specific antigen in a screened population.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Br J Urol. 1997 May;79(5):756-62. doi: 10.1046/j.1464-410x.1997.00130.x. Br J Urol. 1997. PMID: 9158515

9

Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.

Rietbergen JB, Kruger AE, Hoedemaeker RF, Bangma CH, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Among authors: bangma ch. J Urol. 1998 Dec;160(6 Pt 1):2121-5. doi: 10.1097/00005392-199812010-00046. J Urol. 1998. PMID: 9817336 Clinical Trial.

10

Screening and early detection of prostate cancer.

Schröder FH, Alexander FE, Bangma CH, Hugosson J, Smith DS. Schröder FH, et al. Among authors: bangma ch. Prostate. 2000 Aug 1;44(3):255-63. doi: 10.1002/1097-0045(20000801)44:3<255::aid-pros11>3.0.co;2-i. Prostate. 2000. PMID: 10906743 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters